These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26248639)

  • 1. The role of carrier ligands of platinum(II) anticancer complexes in the protein recognition of Pt-DNA adducts.
    He Y; Yuan J; Qiao Y; Wang D; Chen W; Liu X; Chen H; Guo Z
    Chem Commun (Camb); 2015 Sep; 51(74):14064-7. PubMed ID: 26248639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
    Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
    Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA fragment conformations in adducts with Kiteplatin.
    Margiotta N; Petruzzella E; Platts JA; Mutter ST; Deeth RJ; Ranaldo R; Papadia P; Marzilli PA; Marzilli LG; Hoeschele JD; Natile G
    Dalton Trans; 2015 Feb; 44(8):3544-56. PubMed ID: 25144401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA.
    Malina J; Natile G; Brabec V
    Chemistry; 2013 Sep; 19(36):11984-91. PubMed ID: 23873652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformer distribution in (cis-1,4-DACH)bis(guanosine-5'-phosphate)platinum(II) adducts: a reliable model for DNA adducts of antitumoral cisplatin.
    Ranaldo R; Margiotta N; Intini FP; Pacifico C; Natile G
    Inorg Chem; 2008 Apr; 47(7):2820-30. PubMed ID: 18284193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring Pt II chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand.
    Kasparkova J; Suchankova T; Halamikova A; Zerzankova L; Vrana O; Margiotta N; Natile G; Brabec V
    Biochem Pharmacol; 2010 Feb; 79(4):552-64. PubMed ID: 19782655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
    J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J; Novakova O; Farrell N; Brabec V
    Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.
    Kasparkova J; Vojtiskova M; Natile G; Brabec V
    Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein interactions with platinum-DNA adducts: from structure to function.
    Chaney SG; Campbell SL; Temple B; Bassett E; Wu Y; Faldu M
    J Inorg Biochem; 2004 Oct; 98(10):1551-9. PubMed ID: 15458816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts.
    Vaisman A; Lim SE; Patrick SM; Copeland WC; Hinkle DC; Turchi JJ; Chaney SG
    Biochemistry; 1999 Aug; 38(34):11026-39. PubMed ID: 10460158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of platinum-DNA adduct repair.
    Chaney SG; Vaisman A
    J Inorg Biochem; 1999 Oct; 77(1-2):71-81. PubMed ID: 10626357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.
    Chaney SG; Campbell SL; Bassett E; Wu Y
    Crit Rev Oncol Hematol; 2005 Jan; 53(1):3-11. PubMed ID: 15607931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
    Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the sequence-dependent effects of platinum-DNA adducts.
    Ramachandran S; Temple BR; Chaney SG; Dokholyan NV
    Nucleic Acids Res; 2009 May; 37(8):2434-48. PubMed ID: 19255091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.
    Zhao Y; Woods JA; Farrer NJ; Robinson KS; Pracharova J; Kasparkova J; Novakova O; Li H; Salassa L; Pizarro AM; Clarkson GJ; Song L; Brabec V; Sadler PJ
    Chemistry; 2013 Jul; 19(29):9578-91. PubMed ID: 23733242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro.
    Kostrhunova H; Vrana O; Suchankova T; Gibson D; Kasparkova J; Brabec V
    Chem Res Toxicol; 2010 Nov; 23(11):1833-42. PubMed ID: 20939593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiolate bridging and metal exchange in adducts of a zinc finger model and Pt(II) complexes: biomimetic studies of protein/Pt/DNA interactions.
    Almaraz E; de Paula QA; Liu Q; Reibenspies JH; Darensbourg MY; Farrell NP
    J Am Chem Soc; 2008 May; 130(19):6272-80. PubMed ID: 18422317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.
    Lovejoy KS; Todd RC; Zhang S; McCormick MS; D'Aquino JA; Reardon JT; Sancar A; Giacomini KM; Lippard SJ
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):8902-7. PubMed ID: 18579768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.